The Laboratory for Molecular Medicine (LMM) is a CLIA-certified clinical diagnostic laboratory operating within the Partners HealthCare Center for Personalized Genetic Medicine (PCPGM). The LMM received its final regulatory approval and began offering testing services in November of 2003. The mission of the LMM is to bridge the gap between research and clinical medicine, translating novel discoveries into cutting-edge tests and accelerating the adoption of new molecular tests into clinical care. An integral component of the mission of the LMM is the incorporation of IT support into the day to day operations of the clinical lab, as well as implementing innovative programs to help physicians stay current on genetic information relevant to their patients. For more information about these and other IT projects, please go to IT Solutions.
We are located in Cambridge, Massachusetts and work to develop gene tests, particularly DNA sequencing assays, for complex as well as traditional single gene disorders within selected clinical areas, initially including hearing loss, cardiovascular disease, and cancer genetics. By focusing on building a deep portfolio of tests in these domains, the LMM seeks to provide the most comprehensive service within these areas, both from the standpoint of the range of tests offered, as well as the depth of clinical knowledge to guide test selection and interpretation.
While direct DNA sequencing assays for inherited gene disorders will continue to be the cornerstone of the laboratory's test offerings for some time to come, the LMM is actively taking advantage of the other technologies available within the PCPGM, particularly in the field of pharmacogenomics and the opportunity for personalized medicine.
If you have any questions, please contact us.